News
Latest News
Washington, D.C. (September 14, 2023)—Rep. Jamie Raskin, Ranking Member of the Committee on Oversight and Accountability, led Democrats in rebuking Committee Republicans for ignoring the growing allegations of ethical failures and conflicts of interest at the Supreme Court and instead defending deep-pocketed corporations over American families seeking access to justice.
Washington, D.C. (July 26, 2023)—Below is Ranking Member Robert Garcia's opening statement, as prepared for delivery, at today's Subcommittee on National Security, the Border, and Foreign Affairs hearing on the Biden Administration's successful diplomatic efforts to de-escalate tensions and free detained Americans.
Washington, D.C. (September 13, 2023)—Below is Ranking Member Jamie Raskin's opening statement, as prepared for delivery, at today's Committee on Oversight and Accountability hearing examining third-party litigation.
Washington, D.C. (September 12, 2023)—Today, Rep. Jamie Raskin, Ranking Member of the Committee on Oversight and Accountability, released the following statement on House Republicans' illegitimate impeachment inquiry:
"The evidence shows no wrongdoing by President Biden, but the GOP is obviously forced to launch an impeachment inquiry regardless of the facts.
Washington, D.C. (September 12, 2023)—This week, Rep. Raul Ruiz, M.D., Ranking Member of the Select Subcommittee on the Coronavirus Pandemic, led every Democratic Member of the Select Subcommittee in sending a letter to Xavier Becerra, Secretary of the Department of Health and Human Services (HHS), requesting information on the Biden Administration's ongoing efforts to prevent and prepare for future pandemics.
Washington, D.C. (September 11, 2023)—Today, Rep. Jamie Raskin, Ranking Member of the Committee on Oversight and Accountability, released the following statement on the status of Republicans' failed investigation of President Biden as the House prepares to come back into session:
Washington, D.C. (August 30, 2023)— Rep. Jamie Raskin, Ranking Member of the Committee on Oversight and Accountability, issued the following statement on the Biden-Harris Administration's announcement that ten drugs will now be eligible for price negotiation under Medicare as a direct result of the Inflation Reduction Act:
Washington, D.C. (August 16, 2023)—Today, Rep. Jamie Raskin, Ranking Member of the Committee on Oversight and Accountability, issued the following statement on the decision by the United States U.S. Fifth Circuit Court of Appeals to restrict access to the U.S. Food and Drug Administration's (FDA) approved abortion medication: